Assessment of Type I Interferon Signaling in Pediatric Inflammatory Disease-Reference-Cited by-同舟云学术

Assessment of Type I Interferon Signaling in Pediatric Inflammatory Disease

Published:2016-12-09 Issue:2 Volume:37 Page:123-132
ISSN:0271-9142
Container-title:Journal of Clinical Immunology
language:en
Short-container-title:J Clin Immunol

Author:

Rice Gillian I.,Melki Isabelle,Frémond Marie-Louise,Briggs Tracy A.,Rodero Mathieu P.,Kitabayashi Naoki,Oojageer Anthony,Bader-Meunier Brigitte,Belot Alexandre,Bodemer Christine,Quartier Pierre,Crow Yanick J.

Funder

European Research Council

ERA-NET Neuron

Agence Nationale de la Recherche

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s10875-016-0359-1.pdf

Reference45 articles.

1. Crow YJ. Type I, interferonopathies: a novel set of inborn errors of immunity. Ann N Y Acad Sci. 2011;1238:91–8.

2. Crow YJ, Manel N. Aicardi-Goutieres syndrome and the type I interferonopathies. Nat Rev Immunol. 2015;15(7):429–40.

3. Banchereau R, Hong S, Cantarel B, et al. Personalized immunomonitoring uncovers molecular networks that stratify lupus patients. Cell. 2016;165(6):1548–50.

4. Greenberg SA, Pinkus JL, Pinkus GS, et al. Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis. Ann Neurol. 2005;57(5):664–78.

5. Frémond ML, Rodero MP, Jeremiah N, et al. Efficacy of the Janus Kinase 1/2 Inhibitor Ruxolitinib in the Treatment of Vasculopathy Associated with TMEM173-Activating Mutations in three children. J Allergy Clin Immunol. 2016.

Cited by 160 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PSMD11 loss-of-function variants correlate with a neurobehavioral phenotype, obesity, and increased interferon response;The American Journal of Human Genetics;2024-07

2. JAK inhibitors in refractory juvenile rheumatic diseases: Efficacy, tolerance and type-I interferon profiling, a single center retrospective study;Journal of Autoimmunity;2024-07

3. Type I interferon pathway in pediatric systemic lupus erythematosus;World Journal of Pediatrics;2024-06-25

4. IFN-signaling gene expression as a diagnostic biomarker for monogenic interferonopathies;JCI Insight;2024-06-17

5. A recurrent missense variant in the E3 ubiquitin ligase substrate recognition subunit FEM1B causes a rare syndromic neurodevelopmental disorder;Genetics in Medicine;2024-06